Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Synthesis and antimycobacterial activity of imidazo[1,2-b][1,2,4,5]tetrazines.

Maslov DA, Korotina AV, Shur KV, Vatlin AA, Bekker OB, Tolshchina SG, Ishmetova RI, Ignatenko NK, Rusinov GL, Charushin VN, Danilenko VN.

Eur J Med Chem. 2019 Sep 15;178:39-47. doi: 10.1016/j.ejmech.2019.05.081. Epub 2019 May 31.

PMID:
31176094
2.

Synthesis, antimicrobial and antiproliferative properties of epi-oligomycin A, the (33S)-diastereomer of oligomycin A.

Lysenkova LN, Saveljev OY, Omelchuk OA, Zatonsky GV, Korolev AM, Grammatikova NE, Bekker OB, Danilenko VN, Dezhenkova LG, Mavletova DA, Scherbakov AM, Shchekotikhin AE.

Nat Prod Res. 2019 May 10:1-9. doi: 10.1080/14786419.2019.1608540. [Epub ahead of print]

PMID:
31075992
3.

Mutations in Efflux Pump Rv1258c (Tap) Cause Resistance to Pyrazinamide, Isoniazid, and Streptomycin in M. tuberculosis.

Liu J, Shi W, Zhang S, Hao X, Maslov DA, Shur KV, Bekker OB, Danilenko VN, Zhang Y.

Front Microbiol. 2019 Feb 19;10:216. doi: 10.3389/fmicb.2019.00216. eCollection 2019.

4.

Draft Genome Sequence of Streptomyces xinghaiensis (fradiae) OlgR, a Strain Resistant to Oligomycin A.

Bekker OB, Vatlin AA, Zakharevich NV, Lysenkova LN, Shchekotikhin AE, Danilenko VN.

Microbiol Resour Announc. 2019 Jan 10;8(2). pii: e01531-18. doi: 10.1128/MRA.01531-18. eCollection 2019 Jan.

5.

A functional study of the global transcriptional regulator PadR from a strain Streptomyces fradiae-nitR+bld, resistant to nitrone-oligomycin.

Vatlin AA, Bekker OB, Lysenkova LN, Shchekotikhin AE, Danilenko VN.

J Basic Microbiol. 2018 Sep;58(9):739-746. doi: 10.1002/jobm.201800095. Epub 2018 Jul 2.

PMID:
29963725
6.

Verification of oligomycin A structure: synthesis and biological evaluation of 33-dehydrooligomycin A.

Lysenkova LN, Saveljev OY, Grammatikova NE, Tsvetkov VB, Bekker OB, Danilenko VN, Dezhenkova LG, Bykov EE, Omelchuk OA, Korolev AM, Shchekotikhin AE.

J Antibiot (Tokyo). 2017 Jul;70(8):871-877. doi: 10.1038/ja.2017.48. Epub 2017 Apr 19.

PMID:
28420869
7.

Draft genome sequence of Mycobacterium tuberculosis strain B9741 of Beijing B0/W lineage from HIV positive patient from Siberia.

Shur KV, Zaychikova MV, Mikheecheva NE, Klimina KM, Bekker OB, Zhdanova SN, Ogarkov OB, Danilenko VN.

Genom Data. 2016 Aug 3;10:61-62. eCollection 2016 Dec.

8.

[Sequencing and analysis of the resistome of Streptomyces fradiae ATCC19609 in order to develop a test system for screening of new antimicrobial agents].

Vatlin AA, Bekker OB, Lysenkova LN, Korolev AM, Shchekotikhin AE, Danilenko VN.

Genetika. 2016 Jun;52(6):723-7. Russian.

PMID:
29368834
9.

Synthesis and antimycobacterial activity of N-(2-aminopurin-6-yl) and N-(purin-6-yl) amino acids and dipeptides.

Krasnov VP, Vigorov AY, Musiyak VV, Nizova IA, Gruzdev DA, Matveeva TV, Levit GL, Kravchenko MA, Skornyakov SN, Bekker OB, Danilenko VN, Charushin VN.

Bioorg Med Chem Lett. 2016 Jun 1;26(11):2645-8. doi: 10.1016/j.bmcl.2016.04.017. Epub 2016 Apr 9.

PMID:
27107949
10.

Draft Genome Sequence of Streptomyces fradiae olg1-1, a Strain Resistant to Nitrone-Oligomycin.

Vatlin AA, Bekker OB, Lysenkova LN, Danilenko VN.

Genome Announc. 2015 Oct 22;3(5). pii: e01252-15. doi: 10.1128/genomeA.01252-15.

11.

Draft Genome Sequences of Two Pyrazinamide-Resistant Clinical Isolates, Mycobacterium tuberculosis 13-4152 and 13-2459.

Maslov DA, Shur KV, Bekker OB, Zakharevich NV, Zaichikova MV, Klimina KM, Smirnova TG, Zhang Y, Chernousova LN, Danilenko VN.

Genome Announc. 2015 Jul 2;3(4). pii: e00758-15. doi: 10.1128/genomeA.00758-15.

12.

Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960.

Maslov DA, Zań≠chikova MV, Chernousova LN, Shur KV, Bekker OB, Smirnova TG, Larionova EE, Andreevskaya SN, Zhang Y, Danilenko VN.

Tuberculosis (Edinb). 2015 Sep;95(5):608-12. doi: 10.1016/j.tube.2015.05.013. Epub 2015 Jun 2.

PMID:
26071666
13.

Draft Genome Sequence of Mycobacterium tuberculosis Strain E186hv of Beijing B0/W Lineage with Reduced Virulence.

Shur KV, Klimina KM, Zakharevich NV, Maslov DA, Bekker OB, Zaychikova MV, Kamaev EY, Kravchenko MA, Skornyakov SN, Zhang Y, Danilenko VN.

Genome Announc. 2015 May 7;3(3). pii: e00403-15. doi: 10.1128/genomeA.00403-15.

14.

[The virulence factors of Mycobacterium tuberculosis: genetic control, new conceptions].

Prozorov AA, Fedorova IA, Bekker OB, Danilenko VN.

Genetika. 2014 Aug;50(8):885-908. Review. Russian.

PMID:
25731019
15.

Draft Genome Sequence of Streptomyces fradiae ATCC 19609, a Strain Highly Sensitive to Antibiotics.

Bekker OB, Klimina KM, Vatlin AA, Zakharevich NV, Kasianov AS, Danilenko VN.

Genome Announc. 2014 Dec 4;2(6). pii: e01247-14. doi: 10.1128/genomeA.01247-14.

16.

Study on retroaldol degradation products of antibiotic oligomycin A.

Lysenkova LN, Turchin KF, Korolev AM, Danilenko VN, Bekker OB, Dezhenkova LG, Shtil AA, Preobrazhenskaya MN.

J Antibiot (Tokyo). 2014 Feb;67(2):153-8. doi: 10.1038/ja.2013.92. Epub 2013 Oct 2.

PMID:
24084683
17.

Synthesis and cytotoxicity of oligomycin A derivatives modified in the side chain.

Lysenkova LN, Turchin KF, Korolev AM, Dezhenkova LG, Bekker OB, Shtil AA, Danilenko VN, Preobrazhenskaya MN.

Bioorg Med Chem. 2013 Jun 1;21(11):2918-24. doi: 10.1016/j.bmc.2013.03.081. Epub 2013 Apr 6.

PMID:
23623676
18.

Regioselective acylation of congeners of 3-amino-1H-pyrazolo[3,4-b]quinolines, their activity on bacterial serine/threonine protein kinases and in vitro antibacterial (including antimycobacterial) activity.

Lapa GB, Bekker OB, Mirchink EP, Danilenko VN, Preobrazhenskaya MN.

J Enzyme Inhib Med Chem. 2013 Oct;28(5):1088-93. doi: 10.3109/14756366.2012.716056. Epub 2012 Sep 7.

PMID:
22957725
19.

[Eukaryotic serine-threonine protein kinase inhibitors programmable lysis induction of Streptomyces lividans].

Bekker OB, Mavletova DA, Liubimova IK, Mironcheva TA, Shtil' AA, Danilenko VN.

Mikrobiologiia. 2012 Mar-Apr;81(2):177-84. Russian. No abstract available.

PMID:
22693826
20.

A novel acyclic oligomycin A derivative formed via retro-aldol rearrangement of oligomycin A.

Lysenkova LN, Turchin KF, Korolev AM, Bykov EE, Danilenko VN, Bekker OB, Trenin AS, Elizarov SM, Dezhenkova LG, Shtil AA, Preobrazhenskaya MN.

J Antibiot (Tokyo). 2012 Aug;65(8):405-11. doi: 10.1038/ja.2012.38. Epub 2012 May 23.

PMID:
22617550
21.

Synthesis and properties of a novel brominated oligomycin A derivative.

Lysenkova LN, Turchin KF, Korolev AM, Danilenko VN, Bekker OB, Trenin AS, Shtil AA, Preobrazhenskaya MN.

J Antibiot (Tokyo). 2012 Apr;65(4):223-5. doi: 10.1038/ja.2012.4. Epub 2012 Feb 8. No abstract available.

PMID:
22318333
22.

New Test System for Serine/Threonine Protein Kinase Inhibitors Screening: E. coli APHVIII/Pk25 design.

Bekker OB, Alekseeva MG, Osolodkin DI, Palyulin VA, Elizarov SM, Zefirov NS, Danilenko VN.

Acta Naturae. 2010 Jul;2(3):110-21.

23.

Search for inhibitors of bacterial and human protein kinases among derivatives of diazepines[1,4] annelated with maleimide and indole cycles.

Danilenko VN, Simonov AY, Lakatosh SA, Kubbutat MH, Totzke F, Schächtele C, Elizarov SM, Bekker OB, Printsevskaya SS, Luzikov YN, Reznikova MI, Shtil AA, Preobrazhenskaya MN.

J Med Chem. 2008 Dec 25;51(24):7731-6. doi: 10.1021/jm800758s.

PMID:
19053831
24.

[Ca2+ -dependent modulation of antibiotic resistance in Streptomyces lividans 66 and Streptomyces coelicolor A3(2)].

Bekker OB, Elizarov SM, Alekseeva MT, Liubimova IK, Danilenko VN.

Mikrobiologiia. 2008 Sep-Oct;77(5):630-8. Russian.

PMID:
19004344

Supplemental Content

Loading ...
Support Center